Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 123 clinical trials
None
Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer

To evaluate the efficacy of Tislelizumab combined with Nab-paclitaxel and Gemcitabine in the treatment of recurrent pancreatic cancer

  • 0 views
  • 04 Jun, 2021
  • 1 location
None
OMEGA Local Ablative Therapy in Oligometastatic NSCLC

Oligometastatic lung cancer (OM-NSCLC) seems to be associated with a better prognosis than usual Stage IV non-small cell lung cancer when radical local therapy of all metastatic sites is administered but the impact of such an approach on overall survival and quality of life remains to be defined by adequately …

platinum doublet
brain metastases
metastasis
cancer chemotherapy
EGFR
  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Safety Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer

Safety, tolerability and efficacy of regorafenib in combination with FOLFIRINOX in patients with RAS-mutated metastatic colorectal cancer: a dose-escalation, phase I/II trial

erythropoietin
measurable disease
international normalized ratio
lipase
platelet count
  • 1 views
  • 27 Nov, 2021
  • 4 locations
None
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC

This is an open-label, multi-center, single arm, phase II study to assess the anti-tumor activity and safety of bemcentinib when given in combination with pembrolizumab in up to 106 participants with previously treated, advanced adenocarcinoma of the lung. The study will enroll three cohorts of participants with previously treated, advanced …

alopecia
tubal ligation
measurable disease
treatment regimen
bgb324
  • 170 views
  • 20 Oct, 2021
  • 13 locations
None
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer

This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an activating EGFR mutation (exon 19 deletion or L858R) who have received and progressed on or after at least 1 EGFR TKI and 1 platinum-based chemotherapy-containing regimen.

  • 3 views
  • 21 Nov, 2021
  • 108 locations
None
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b

First-in-human, Phase 1b/2 safety study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an intravenous infusion once every four weeks. Patients with tumor types likely to express NaPi2b were enrolled in dose escalation. Patients with platinum-resistant ovarian cancer and non-small cell lung cancer (adenocarcinoma subtype) are being enrolled …

lung cancer
measurable disease
cancer
programmed cell death 1 ligand 1
monoclonal antibodies
  • 63 views
  • 01 Oct, 2021
  • 62 locations
None
SGM-101 in Colorectal Lung Metastases

location and extensiveness. SGM-101 already proven to be safe and valuable in colorectal cancer. This study aims to prove feasibility for colorectal lung metastases.

  • 0 views
  • 13 Feb, 2021
  • 2 locations
None
Stereotactic Radiotherapy (SBRT) of Lung Metastasis

The purpose of this institutional protocol is to offer SBRT to selected patients in a controlled environment to refine treatment techniques (including dose/fractionation schedules) and standardize follow-up. SBRT has been in clinical use for over a decade in some institutions and the available data suggest that it can be used …

stage iv non-small cell lung cancer
ct scan
stereotactic body radiation therapy
metastasis
lung carcinoma
  • 1 views
  • 10 Oct, 2021
  • 1 location
None
BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases

This is a Phase 2 study of an investigational drug, BIO-11006, for the treatment of lung metastases in pediatric patients with advanced osteosarcoma or Ewing's sarcoma. This study will enroll up

  • 0 views
  • 27 Apr, 2021
  • 1 location
None
In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma

lung will be treated as current standard of care - either surgery or radiation) as a control lung. The patients will undergo a posterolateral thoracotomy. Lung metastases will be identified by

cancer
sarcoma
pulmonary metastasis
doxorubicin
metastasis
  • 41 views
  • 08 Apr, 2021
  • 1 location